Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of early switch to everolimus from cyclosporine A in
de novo renal transplant recipients by assessing rejection rate everolimus trough levels,
other safety laboratory variables and adverse events.